

Dacikast 60mg Tablet (Daclatasvir)
Manufactured By
Aprazer Healthcare Pvt Ltd
Pack Of
28
Salt Composition
Daclatasvir
Storage
Keep in cold place
ALL SUBSTITUTES
Overview
Dacikast 60mg Tablet is an antiviral medicine. It is prescribed to treat chronic hepatitis C virus (HCV) infection. It contains daclatasvir as an active ingredient. This tablet works by reducing the load of hepatitis C virus in the body and eliminating the virus from the blood over time. It should be taken in doses and durations as advised by the doctor. Don't take more than the recommended dose.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | dacikast |
| Generic / Active Ingredient | Daclatasvir |
| Strength | 60 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | Aprazer Healthcare Pvt Ltd |
| Pack Size | 28 |
| Prescription Required | Yes |
| Therapeutic Categories | Hepatitis Medicines |
| Uses | hepatitis |
Uses and Indications
Hepatitis C
Side Effects of Dacikast 60mg Tablet
Dacikast 60mg Tablet (Daclatasvir 60mg) is a strong antiviral medicine that may show certain adverse effects while having a manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects, contact your healthcare professional immediately.
Some common side effects include:
● Fatigue
● Headache
● Nausea
● Insomnia (difficulty sleeping)
● Anemia (low number of red blood cells)
Dacikast 60mg Tablet Dosage and How To Take It
The doctor determines the dosage and duration of the Dacikast 60mg Tablet (Daclatasvir 60mg) as per the severity of the infection as well as the age & overall health condition of the patients. Swallow it as a whole with water and don't chew, crush or break the tablet.
This tablet may be taken with or without food. In case of an overdose of this tablet, contact your doctor or any healthcare provider and seek medical attention immediately.
Safety Advice for Dacikast 60mg Tablet
- ● Alcohol: Avoid the consumption of alcohol while taking the Dacikast 60mg Tablet (Daclatasvir 60mg), as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
- ● Pregnancy: Do not take the Dacikast 60mg Tablet without consulting the doctor in case of pregnancy, as it is unsafe to take it during this period.
- ● Breastfeeding: Dacikast 60mg Tablet (Daclatasvir 60mg) is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet, as limited data is available that shows significant risk.
- ● Driving: Dacikast 60mg Tablet (Daclatasvir 60mg) may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
- ● Kidney: Dacikast 60mg Tablet is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this tablet.
- ● Liver: Dacikast 60mg Tablet (Daclatasvir 60mg) is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this tablet.
FAQs About Dacikast 60mg Tablet
What are the uses of Dacikast 60mg Tablet?
It is an antiviral medicine used in the treatment of hepatitis C virus (HCV) infection as prescribed by the doctor.
Is it safe to take the Dacikast 60mg Tablet during pregnancy or breastfeeding?
Consumption of Dacikast 60mg Tablet (Daclatasvir 60mg) during pregnancy is considered to be unsafe, especially without a doctor's advice. However, it is safe to take this medicine during breastfeeding if prescribed by the doctor.
Is it safe to take other medicine with Dacikast 60mg Tablet?
As Dacikast 60mg Tablet can interact with some medicine. It is advisable to inform your doctor about any medicine you are taking.
What are the common side effects of Dacikast 60mg Tablet (Daclatasvir 60mg)?
There are some common side effects of taking the Dacikast 60mg tablet such as headache, nausea, vomiting, fatigue, stomach pain, etc.
How to take Dacikast 60mg Tablet (Daclatasvir 60mg)?
This tablet may be taken with or without food and should be swallowed with water as prescribed by the doctor.
References
● Pol, S., Bourliere, M., Lucier, S., Hezode, C., Dorival, C., Larrey, D., ... & ANRS/AFEF HEPATHER study group. (2017). Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. Journal of hepatology, 66(1), 39-47.
● McCormack, P. L. (2015). Daclatasvir: a review of its use in adult patients with chronic hepatitis C virus infection. Drugs, 75(5), 515-524.
● Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., ... & Grasela, D. M. (2014). Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. New England Journal of Medicine, 370(3), 211-221.
● Wyles, D. L., Ruane, P. J., Sulkowski, M. S., Dieterich, D., Luetkemeyer, A., Morgan, T. R., ... & Ackerman, P. (2015). Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1. New England Journal of Medicine, 373(8), 714-725.
● Lee, C. (2013). Daclatasvir: potential role in hepatitis C. Drug design, development and therapy, 1223-1233.
Marketer Details
Aprazer Healthcare Pvt Ltd
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.




